Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.

Autor: Hu Z; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Mao JH; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA., Curtis C; Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA., Huang G; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Gu S; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Heiser L; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Lenburg ME; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA., Korkola JE; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Bayani N; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA., Samarajiwa S; MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK., Seoane JA; Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA., Dane MA; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Esch A; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Feiler HS; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Wang NJ; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Hardwicke MA; GlaxoSmithKline, Collegeville, PA, 19425, USA., Laquerre S; GlaxoSmithKline, Collegeville, PA, 19425, USA., Jackson J; GlaxoSmithKline, Collegeville, PA, 19425, USA., Wood KW; Cytokinetics, Inc., South San Francisco, CA, 94080, USA., Weber B; GlaxoSmithKline, Collegeville, PA, 19425, USA., Spellman PT; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA., Aparicio S; Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada., Wooster R; GlaxoSmithKline, Collegeville, PA, 19425, USA., Caldas C; Cancer Research UK, Cambridge Institute, Cambridge, UK. carlos.caldas@cancer.org.uk., Gray JW; Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. Grayjo@ohsu.edu.
Jazyk: angličtina
Zdroj: Breast cancer research : BCR [Breast Cancer Res] 2017 Feb 09; Vol. 19 (1), pp. 17. Date of Electronic Publication: 2017 Feb 09.
DOI: 10.1186/s13058-017-0809-6
Databáze: MEDLINE